Leptin expression was elevated in breast cancer patients who developed post-chemotherapy fatigue, suggesting that Leptin is a potential biomarker of post-chemotherapy fatigue in adenocarcinoma and that the mechanism may be that high Leptin expression activates TNF-α, thereby promoting post-chemotherapy fatigue in adenocarcinoma [19]. This evidence concerns the gene LEP and adenocarcinoma.